Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Aoxing Completes Trial of TCM Product for Menstrual Pain

publication date: Jan 5, 2010
China Aoxing Pharma (中国奥星药业) completed a Phase II trial of a TCM product, oral TJSL capsules, for primary dysmenorrhea (menstrual pain) in adult women. China Aoxing expects to report top-line results in the coming weeks. China Aoxing bought the drug in May 2009 from Professor X. Tian, a well-known China gynecologist for an undisclosed amount. The Phase II trial was already underway at the time of purchase. More details...

Stock Symbol: (OTCBB: CAXG)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital